HK Stock MarketDetailed Quotes

06108 NEW RAY MEDIC

Watchlist
  • 0.043
  • 0.0000.00%
Not Open May 20 16:08 CST
71.89MMarket Cap-2.26P/E (TTM)

About NEW RAY MEDIC Company

We are a large-scale pharmaceutical distributor originally founded in Zhejiang Province, headquartered in Hangzhou City, Zhejiang Province. We are mainly engaged in pharmaceutical distribution business in China (with a focus on Zhejiang Province). We are mainly a provincial distributor, and also a national distributor for some of our products. We are engaged in pharmaceutical distribution business from the stage of obtaining product distribution rights from suppliers, market research and development of new products, assisting and cooperating with our suppliers in centralized bidding, purchasing, procurement, sales and marketing, storage and shipping of products to our distributor customers. Most of our products will instead be distributed by our distributor customers under exclusive regional terms to end customers, mainly hospitals and medical institutions throughout China. All pharmaceutical products distributed by the Group are generic pharmaceutical products. In order to strengthen our position and become one of the leading distributors of pharmaceutical products in Zhejiang Province, we plan to implement the following business goals and strategies: Continued expansion through the acquisition of new exclusive distribution rights; and Continue to consolidate and expand our market share, distribution network and marketing efforts.

Company Profile

Symbol06108
Company NameNEW RAY MEDIC
ISINBMG647461117
Listing DateJun 16, 2015
FoundedAug 9, 2012
Registered AddressBermuda
Chairmanqiuqin wang
Secretaryrisheng wu
Audit InstitutionDahua Ma Shiyun Certified Public Accountants Co., Ltd.
Company CategoryOther
Registered OfficeClarendon House 2 Church Street Hamilton HM 11 Bermuda
Head Office and Principal Place of BusinessRoom 911B, 9th Floor, Newport Centre Tower 1, 30 Canton Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees29
MarketHong Kong motherboard
Phone21522030
Emailinfo@newraymedicine.com
Business Xinrui Pharmaceutical International Holdings Co., Ltd. is a company mainly engaged in the distribution and trading business of pharmaceutical products. The company operates through two divisions. The Pharmaceutical Products Distribution and Trade Division is mainly engaged in the distribution and trading of injectable drugs and chemical reagents. The Marketing and Promotion Services Division is mainly engaged in the marketing and promotion service business of providing pharmaceuticals. The company mainly operates in the domestic market of China.

Company Executives

  • Name
  • Position
  • Salary
  • qiuqin wang
  • Presidencies, CEO, Executive Director, Chairman of the Corporate Governance Committee, Authorized Representative
  • --
  • xueping chu
  • Executive Director
  • --
  • wan zhou
  • Executive Director
  • --
  • zhijian liang
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Remuneration Committee Chairman, Audit Committee Members
  • --
  • qianming li
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • --
  • lixian shi
  • Independent Non-Executive Director, Member of the Corporate Governance Committee, Remuneration Committee Members, Nomination Committee Members, Audit Committee Members
  • --
  • risheng wu
  • Chief Financial Officer, Authorized Representative, Company Secretary
  • --

Market Insights

Tariff Storm Hits: Hedge with ETFs? Tariff Storm Hits: Hedge with ETFs?

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

Unlock Now

Discussing

中美大降關稅!如何抓住市場交易機會?
中美關稅超預期降溫,市場迎來久違狂歡。5月12日下午,中方公佈中美日內瓦經貿會談聯合聲明,美方取消共計91%的加徵關稅,中方相應取消91%的反制關稅,美方暫停實施24%的「對等關稅」,中方相應暫停實施24%的反制關稅。聲明公佈後,港美股當日應聲暴漲,修復至關稅前水平。13日,特朗 Show More

Positive signs keep on coming! China's assets explode across the board

Following the announcement of a series of previous stimulus policies, and DeepSeek's popularity with its low cost and high performance advantages, China Securities sounded the horn of counterattack this year.